Northeast Investment Management Abbott Laboratories Transaction History
Northeast Investment Management
- $2.09 Billion
- Q1 2025
A detailed history of Northeast Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Northeast Investment Management holds 92,709 shares of ABT stock, worth $12.1 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
92,709
Previous 93,661
1.02%
Holding current value
$12.1 Million
Previous $10.6 Million
16.09%
% of portfolio
0.59%
Previous 0.48%
Shares
31 transactions
Others Institutions Holding ABT
# of Institutions
3,412Shares Held
1.34BCall Options Held
10.5MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$22.1 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.1 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.9 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.09 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...